Skip to main content
. 2012 Aug 15;2012:404752. doi: 10.1155/2012/404752

Table 3.

Peripheral blood immunoglobins and complements of patients with UC (x- ± s, g/L).

Group n IgG IgA IgM C3 C4
BT AT BT AT BT AT BT AT BT AT
Experiment group 41 12.7 ± 2.8 12.3 ± 2.4 2.36 ± 0.84 2.26 ± 0.76 1.56 ± 0.73 1.43 ± 0.70 1.08 ± 0.34 1.03 ± 0.33 0.31 ± 0.12 0.30 ± 0.11
Control group 41 13.2 ± 2.9 12.9 ± 2.8 2.48 ± 1.23 2.42 ± 1.01 1.51 ± 0.80 1.48 ± 0.72 1.06 ± 0.28 1.02 ± 0.27 0.27 ± 0.10 0.27 ± 0.11
t value 0.794 1.042 0.516 0.811 0.296 0.319 0.291 0.311 1.640 1.235
P value 0.430 0.299 0.633 0.419 0.765 0.756 0.77 0.742 0.106 0.226

BT stands for “before treatment”. AT stands for “two months after treatment”. The statistics using t-test.

HHS Vulnerability Disclosure